Scribd Logo
Загрузить

Добро пожаловать в Scribd!

  • RD TH TH TH TH TH TH TH

    Загружено:

    Renata Yolanda
    19 просмотров2 страницы
    KASUS

    Оригинальное название

    Bagan Kasus

    Авторское право

    © © All Rights Reserved

    Доступные форматы

    DOCX, PDF, TXT или читайте онлайн в Scribd

    Этот документ был вам полезен?

    Это неприемлемый материал?

    Пожаловаться на этот документ
    KASUS

    Авторское право:

    © All Rights Reserved
    Скачайте в формате DOCX, PDF, TXT или читайте онлайн в Scribd
    Отметить как неприемлемый контент
    19 просмотров2 страницы

    RD TH TH TH TH TH TH TH

    Загружено:

    Renata Yolanda
    KASUS

    Авторское право:

    © All Rights Reserved
    Скачайте в формате DOCX, PDF, TXT или читайте онлайн в Scribd
    Отметить как неприемлемый контент
    из 2

    DISEASE COURSE TIMELINE

    When chosen as a case

    April 17th,2019 April 30th, 2019 May 7th, 2019 June 3rd, 2019 June 4th-8th, 2019 March 9th-10th, 2019

    Admitted to hospital with Pale (+), fever (+), bone Pale (+), fever (+), Pale (+), fever (-), bone Pale (-), fever (-), bone Pale (-), fever (-), bone
    complaints: pale, bone pain pain (-), bleeding (-) bone pain (-), bleeding pain (-), bleeding (-) pain (-), bleeding (-) pain (-), bleeding (-)
    and fever (-)

    Supportive examination: PE: Head: anemic PE: Head: anemic PE: Head: anemic PE: Head: anemic
    PE: Head: anemic BMP :predominance with conjunctiva (+), anicteric conjunctiva (+), anicteric conjunctiva (-), anicteric conjunctiva (-), anicteric
    conjunctiva (+), anicteric lymphoblast L2 morphology sclera.Abdomen: Liver 4-4 sklera, Abdomen: Liver 3- sklera, Abdomen: Liver 3- sklera, Abdomen: Liver 3-
    sclera.Abdomen: Liver 4- with blast and smudge cells cm BCM, spleen schuffner 3 cm BCM, spleen 3 cm BCM, spleen 3 cm BCM, spleen
    4 cm BCM, spleen Immunophenotyping : B III schuffner II schuffner II schuffner II
    schuffner III lineage with gating of the blast
    with positive HLA-DR, CD10,
    CD19, CD20.
    Laboratory: CSF exam : Working diagnosis: Laboratory: Hb: 10.5g/dl, Hct
    cloudy, leukocyte 600/L, High Risk B-cell ALL + Laboratory: Hb:10,2 g/dl,
    : 30.5 %, leukocyte 5.500/L,
    Laboratory : Hb : 2.7 g/dl, nonne (+), pandy (+), blast CNS Leukemia (C91.00) leukocyte 4.200/L,
    trombocyte 103.000/ul, ANC
    leukocyte 202.900/L, Working diagnosis: (+) thrombocyte 85.000/ul,
    5.060 cell/ mm3. AST :35 U/L
    trombocyte 17.000/L, High Risk B-cell ALL ANC 4,032 cell/ mm3.
    ALT: 20 U/L. Ur 21 mg/dL, Cr
    blood smear : Suggestive: 0.5 mg/dL. Sodium 136,
    ALL
    potassium 4.0, Calcium 8.0,
    Working diagnosis: Therapy :
    Therapy: High Risk B-cell ALL + CNS - High-risk ALL consolidation
    Working diagnosis:
    - Nutrition according Leukemia (C91.00) phase Indonesia Protocol
    High Risk B-cell ALL +
    to RDA 2016 +CNS Leukemia Working diagnosis:
    Working diagnosis: CNS Leukemia (C91.00)
    (Modified) High Risk B-cell ALL +
    Suspect ALL
    - Nutrition according to RDA CNS Leukemia (C91.00)
    Therapy :
    - High-risk ALL induction
    Therapy :
    phase Indonesia Protocol
    Therapy: - High-risk ALL Therapy :
    2016 +CNS Leukemia
    - PRC and platelet transfusion consolidation phase - High-risk ALL consolidation
    (Modified)
    - Nutrition according to RDA Indonesia Protocol 2016 phase Indonesia Protocol
    - Nutrition according to RDA
    Plan: BMP and immuno- +CNS Leukemia 2016 +CNS Leukemia
    phenotyping (Modified) (Modified)
    - Nutrition according to - Nutrition according to
    RDA RDA

    Вам также может понравиться